Clear Gene

Clear Gene is a diagnostics company that combines machine learning and genomics to detect residual solid tumor after cancer treatment to reduce unnecessary treatments. Clear Gene was founded in 2012 and is based in San Carlos, California.

Clear Gene has developed treatments to help patients prevent and withstand residual diseases and cancers that may remain after they have received treatments. The company is composed of a group of scientists that work with clinicians that work in cancer care.

Preventing clinical outcomes that are unfavorable for patients is what Clear Gene focuses on when developing their molecular diagnostics technologies. Their medical devices are able to analyze bio-markers from solid tissue in real-time, on location.

During the COVID-19 pandemic the company supported hospitals and clinical labs by running nucleic tests in order to diagnose SARS CoV-2 tests. Their platform allows them to validate molecular assays. Their lab that is used to provide PCR and isothermal amplification in order to run nucleic acid tests is located in San Carlos, California, United States.